kabutan

Immuno-Biological Laboratories Co., Ltd.(4570) Summary

4570
TSE Growth
Immuno-Biological Laboratories Co., Ltd.
1,387
JPY
-9
(-0.64%)
Apr 28, 3:30 pm JST
8.71
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
1,380.1
Apr 28, 11:45 pm JST
Summary Chart Historical News Financial Result
PER
48.7
PBR
7.33
Yield
0.43%
Margin Trading Ratio
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
1,397 JPY 8.76 USD
Previous Close Apr 27
1,396 JPY 8.75 USD
High Apr 28, 9:04 am
1,406 JPY 8.82 USD
Low Apr 28, 9:20 am
1,382 JPY 8.67 USD
Volume
41,800
Trading Value
0.06B JPY 0.36M USD
VWAP
1389.85 JPY 8.73 USD
Minimum Trading Value
138,700 JPY 871 USD
Market Cap
0.01T JPY 0.08B USD
Number of Trades
230
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
3,167
1-Year High Dec 30, 2025
93,496
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 1,059,700
Apr 17, 2026 0 1,050,000
Apr 10, 2026 0 1,077,000
Apr 3, 2026 0 1,067,800
Mar 27, 2026 0 1,099,400
Company Profile
Immuno-Biological Laboratories Co., Ltd. manufactures and sells research reagents and offers contract services. The silkworm development business has been suspended. The company has entered the cosmetics business.
Sector
Pharmaceuticals
Immuno-Biological Laboratories Co., Ltd. primarily manufactures and sells antibody-based research reagents, in vitro diagnostic pharmaceuticals, and raw materials for in vitro diagnostic pharmaceuticals. The company also develops pharmaceutical seeds utilizing antibody production technology and provides the lipoprotein profiling analysis service "LipoSEARCH". Additionally, the company offers contract services for mass production of proteins and antibodies using genetically modified silkworm technology. Furthermore, in the cosmetics sector, Immuno-Biological Laboratories Co., Ltd. focuses on developing and selling products containing silkworm-derived "NeoSilk-Human Collagen I".